Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
ConditionLung Cancer (Diagnosis)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Vienna
About this trial
During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.
Eligibility criteria
Qualifiers
Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
indication for mediastinal staging
Disqualifiers
None
Trial design
Treatments tested in this trial
- EBUS-TBNA
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov